INTRODUCTION
Many RNA viruses make use of the plasma membrane of the host cell during assembly. There is now overwhelming evidence that all major envelope polypeptides of toga-, rhabdo-, myxoand oncornaviruses are encoded by the viral genome and that the host proteins are almost completely eliminated from budding sites with the exception of certain enzymes (for reviews, see Rott & Klenk, 1977; Burns & Allison, 1977; Lindenmann, 1977; Simons & Garoff, 1980) . In apparent contradiction to this high degree of specificity is the peculiar case of pseudotypes. Such particles have the core of one virus surrounded by an envelope with protein largely derived from a second virus (Z/lvada, 1977) . Nevertheless, there is a specific selection, because although the enveloped viruses can assemble surface glycoproteins of other even entirely unrelated viruses, they do not seem to acquire glycoproteins derived from the host plasma membrane.
At present, it is generally accepted that cell-specific glycoproteins (gp) are not assembled into enveloped viruses. However, occasiohally, results have been reported indicating the presence of cellular gps in virus envelopes as exceptions to this rule; however, when carefully re-tested these were proved to be in fact viral gps (for review, see Z~tvada, 1982 ). An example is the molecules of the major histocompatibility complex, the H-2 antigens. Several groups of authors reported the 0022-1317/83/0000-5527 $02.00© 1983 SGM presence of H-2 antigens on the surface of murine leukaemia virus (MuLV) (Aoki & Takahashi, 1972) , or within the viruses (Bubbers et al., 1978; Chen& Lilly, 1979) . Also, vesicular stomatitis virus (VSV) has been reported to assemble the molecules of H-2 antigens efficiently from mouse L cells (Hecht & Summers, 1972 , 1976 . However, in our previous work (Calafat et al., 1981) we could not confirm the presence of H-2 antigens either inside or on the surface of MuLV and mouse mammary tumour virus (MMTV) using a highly sensitive method, immunoelectron microscopy (IEM) with monoclonal antibodies to H-2. However, it could be demonstrated that the conventional anti-H-2 sera were contaminated with antibodies against MuLV and/or MMTV because they reacted with the C-particles from the Gross virus-producing leukaemia cell lines irrespective of their H-2 specificity; moreover, they reacted with MMTV-producing mammary tumour cells of mouse strains whose peripheral lymphoid cells did not react (Calafat et al., 1981) .
In this paper, the presence of H-2 antigens on VSV envelope was studied by IEM using monoclonal antibodies and conventional sera against H-2 to see whether we could confirm the results of Hecht & Summers (1972 , 1976 . Using the same technique and taking advantage of the availability of monoclonal antibodies against other cell surface gps, it was in addition investigated whether any of these gps were incorporated into the viral envelope during the assembly of MuLV and VSV particles. The gps studied were Pgp-1 (Trowbridge et al., 1982) , T-200 (Trowbridge, 1978) and Thy-1 (Campbell et al., 1981) and for this study we have chosen the B W5147, BuEL4 and L 1210V leukaemia cell lines. BW5147 and BuEL4 produced abundant MuLV particles, could easily by infected with VSV, and contained large quantities of H-2, Pgp-1, T-200 and Thy-1 antigens. The L1210V cell line also produced abundant MuLV particles and MuLV antigens on the cell surface and was Thy-l-negative.
METHODS
Cells. The leukaemia cell lines used were: BW5147 (BW5), an AKR-derived thymoma with haplotype H-2 k, Thy-1.1 ÷ (Trowbridge, 1978) , originating from the Salk Institute, La Jolla, Ca., U.S.A. ; BuEL4, a subline of EL4 (see Gorer & Kaliss, 1959) , with haplotype H-2 b, Thy-1.2÷; L1210V (Zhk-Nejmark et al., 1978) , derived from a transplantable DBA2 lymphoma presumably of B lymphocyte origin, maintained since 1969 at the Department of Tumor Immunology, Ludwik Hirszfeld Institute, Wroclaw, Poland and kindly provided by Dr J. Steuden, with haplotype H-2 d, Thy-1.2-. All three cell lines produce many Gross virus particles, and L1210V in addition MMTV particles; they were maintained in Dulbecco's modified Eagle's minimal essential medium supplemented with 10~o newborn calf serum.
Viruses. Wild-type VSV strain San Juan was originally obtained from Dr S. Schlesinger (St. Louis, Mo., U.S.A.) and kindly provided by Dr B. van der Zeijst (Institute of Virology, Veterinary Faculty, University of Utrecht, The Netherlands). The viruses were cloned twice before stocks were prepared, in BHK-21 cells. The BW5 and BuEL4 cell lines were infected with VSV. Briefly, cultures with more than 98~o viable cells, measured by trypan blue exclusion, were infected with wild-type VSV at a multiplicity of infection of 20. After adsorption for 60 min at 37 °C, growth medium was added and the cells were incubated at 37 °C. Antisera. The anti-H-2 sera, monoclonal antibodies against H-2 and rat anti-Gross serum have been described in detail elsewhere (Calafat et al., 1981) . Briefly, the anti-H-2 sera of the ASA series were prepared by repeated alloimmunization with spleen and thymus cell suspensions. Monoclonal antibody against K b was a gift of Dr G. K6hler (KShler et al., 1981) and monoclonal antibodies B22-249-R. 1 and H100-5-R4 were a gift of Dr G. J. Hfimmerling (Lemke et al., 1978) . The gps recognized by each of these sera are listed in Tables 1 and 2 . Rat antiGross virus serum was obtained from serum of SD rats transplanted with a syngeneic tumour induced by AKR leukaemia virus (Calafat et al., 1981) .
Monoclonal antibodies 142/5 (Trowbridge et al., 1982) , I3/2 (Trowbridge, 1978) and T24/31 (Dennert et al., 1980) were kindly provided by Dr I. S. Trowbridge. Monoclonal antibody 19-E12 (Bernstein et al., 1980) was kindly provided by Dr M. E. Lostrom. The gps detected by these monoclonal antibodies are described in Tables 1  and 2 . Monoclonal antibodies 142/5, 13/2 and T24/31 are rat IgG and were obtained as culture supernatants from the hybridomas and therefore are not contaminated by antibodies against MuLV. Monoclonal antibody 19-El 2 is mouse IgG and was obtained as ascites fluid from mice bearing the hybridoma. To ensure that this monoclonal antibody was not contaminated with antibodies against MuLV from the hosts, we tested it by immunofluorescence and IEM on the L1210V cell line (MuLV + and Thy-1.2-), with a negative result. In addition, Dr M. E. Lostrom provided us later with monoclonal antibody 19/VEI2 obtained from the culture supernatant of the same hybridoma as 19-E12.
Preparation offerritin and haemocyanin conjugates. Goat anti-mouse IgG (GAM) and goat anti-rat IgG (GARa) (Nordic Pharmaceutical, Tilburg, The Netherlands) were coupled to ferritin with glutaraldehyde (Calafat et at., 1974) . GAM was coupled to haemocyanin with glutaraldehyde (Jeng et al., 1978 Immunoeytochemieal staining. Labelling was performed at room temperature under constant agitation and 2 × 106 cells grown in suspension were used in each experiment. They were rinsed in Hanks' solution, incubated for 1 h in 20 txl specific antiserum at a concentration of 1 : 1 or undiluted (conventional anti-H-2 sera and rat anti-Gross serum) or diluted 1 : 10 to 1 : 150 (monoclonal antibodies) with Hanks' solution. After three rinses, the cells were incubated for 1 h in 20 p.1 of the corresponding ferritin-or haemocyanin-labelled anti-IgG at a concentration of I : 1 and rinsed again three times in Hanks' solution.
After antibody incubation the cells were fixed in 2.5 ~ glutaraldehyde in 0.1 M-cacodylate buffer pH 7.2, postfixed in 1 ~ osmium tetroxide in the same buffer, dehydrated and embedded in a mixture of Epon and Araldite. Thin sections were stained with uranyl acetate and lead hydroxide. The preparations were examined with Philips electron microscopes, EM 300 and EM 301.
For fixation before or between antibody incubations, 0-125 ~ glutaraldehyde in cacodylate buffer was used for 5 min followed by three 15 rain rinses in Hanks' solution. As a control, in all experiments cells were first incubated with normal mouse or rat sera, then with the corresponding anti-lgG conjugate. These controls were negative with the exception of the normal mouse serum, which sometimes reacted to some extent with the virus envelope, mainly that of C particles, and the cell surface. This mouse serum was derived from C57BL/6 mice and probably contained antibodies to the endogenous MuLV.
RESULTS
AS was expected, when incubation of the cells with antisera took place at room temperature, the redistribution of the antigen-antibody complexes was mainly in large patches (Fig. 1) . When the cells were fixed with glutaraldehyde before incubation with the antisera, no redistribution could take place and the labelling was seen as granules of ferritin evenly distributed on the cell membrane ( 
Distribution of glycoproteins on VSV-infected BW5 leukaemia cells (haplotype H-2 k, Thy-1.1 +)
The results are summarized in Table 1 . Monoclonal antibody against H-2K k (100-5-R4) and ASA-5 (H-2K k) and ASA-11 (H-2D k) sera reacted weakly with the cell membrane of VSVinfected BW5 leukaemia cells. However, the same sera reacted two or three times more strongly with uninfected BW5 cells. No reaction was observed on the envelope of MuLV and VSV particles with monoclonal antibody 100-5-R4. However, ASA-5 reacted with MuLV and weakly with VSV, and ASA-11 reacted weakly with MuLV and very weakly with VSV; this was as expected, because these conventional antisera are contaminated with antibodies against endogenous MuLV (Calafat et al., 1981) .
The I42/5, I3/2, T24/31, 19-E12 and 19-VE12 monoclonal antibodies reacted strongly with VSV-infected BW5 cell membrane ( Fig. 1 to 3 ). I42/5 and I3/2 did not react with MuLV and VSV envelope ( Fig. 1 and 2) . However, about half of the MuLV and VSV particles were partially labelled with T24/31 monoclonal antibody against the Thy-1 molecule and 19/E 12 and 19-VE 12 monoclonal antibodies against the Thy-1.1 alloantigen (Fig. 3) .
Distribution of glycoproteins on VSV-infected BuEL4 leukaemia cells (haplotype H-2 b, Thy-1.2 +)
The results are summarized in Table 2 . Monoclonal antibodies against H-2K b (Fig. 4) and against H-2D b (B22-249-R. 1) and ascites ASA-1 (H-2 b) serum reacted extensively with the membrane of BuEL4 cells whether infected with VSV or not. No reaction was observed on the envelope of MuLV and VSV (Fig. 4 ) with the monoclonal antibodies against H-2. Only in one of three incubations with ascites ASA-1 serum was a weak labelling of a few MuLV and VSV particles found to be due to contamination of this serum with antibodies against endogenous MuLV (Calafat et al., 1981) . +, almost the whole cell surface; + , few groups of ferritin. , partially labelled; +, -, about half of the virus partially labelled and half negative; _+, slightly labelled over the non-specific background; +, -, some virus slightly labelled over the nonspecific background; -, not labelled. 
Redistribution of Thy-1.1 antigens and MuLV antigens on the surface of BW5 leukaemia cells
A possible physical association of Thy-1.1 and MuLV antigens was studied with antibodyinduced redistribution of both antigens to see whether co-patching occurs. The experiments summarized in Table 3 show that after incubation of unfixed BW5 cells with monoclonal antibody against Thy-1.1 and anti-Gross virus serum and the respective conjugates at room temperature, both labels were distributed in patches separated from each other (Fig. 7) . When unfixed cells were incubated with one antiserum, then fixed and afterwards incubated with the second antiserum, the antigen-antibody complex formed with the first antiserum was completely concentrated into patches and that formed with the second antiserum remained scattered on the cell membrane (Fig. 8) . These results show that there is no co-patching of Thy-1.1 antigen with MuLV antigens on the BW5 cell surface and also no co-redistribution of viral antigens with Thy-1.1 antigens. Therefore, these antigens are on different molecules, which are not in extensive, close or strong physical association. In all these experiments the envelope of C particles was labelled all around with ferritin (conjugate used for rat anti-Gross serum) and at the same time about half of the particles were partially labelled with haemocyanin (conjugate used for monoclonal antibodies 19-E12 anti-Thy-1.1) (Fig. 9, 10) .
As a control in all redistribution experiments, we incubated the cells with monoclonal antibody 19-E12 and GAM-haemocyanin with or without intermittent fixation, followed by incubation with buffer and GARa-ferritin. A separate cell sample was incubated with rat antiGross serum and GARa-ferritin with or without intermittent fixation, followed by incubation with buffer and GAM-haemocyanin. The extent of the cell membrane labelled with each antiserum was similar to the extent labelled in the redistribution experiments. This suggests that no blocking took place between these antisera in the redistribution experiments. This could have happened if both antigens had been on the same or closely associated molecules.
Presence of Thy-1 antigens on MuL V and VSV particles
The results described in Tables 1 and 2 showed that, with the exception of Thy-1, the cell membrane gps studied are excluded from the MuLV and VSV envelope during budding from the cell surface of BuEL4 and BW5 cells. The incubation experiments using uninfected BW5, with anti-Thy-1.1 and anti-Gross (Table 3 ), showed that Thy-1.1 can be incorporated into the envelope of MuLV particles and that no strong physical association occurs between this gp and MuLV gps on the BW5 cell membrane. However, the presence of Thy-1 on the VSV envelope can never indicate with certainty that Thy-1 is also incorporated i n t h e VSV envelope, because some of the VSV particles produced by BuEL4 and BW5 cells are pseudotypes with envelope components of MuLV. It cannot thus be excluded that Thy-I is present only in these VSV pseudotypes due to a possible affinity with MuLV gps. However, this possibility seems less likely due to the failure of co-patching of Thy-1.1 and MuLV antigens on the surface of BW5 cells described in the redistribution experiments of Table 3 . To ascertain whether Thy-1 is incorporated in the VSV envelope, the following experiment was done. VSV-infected BW5 cells were incubated with both rat anti-Gross and monoclonal antibody 19-E12 and their corresponding conjugates. In one of three experiments extensive endocytosis of rat anti-Gross antigen complexes occurred; this experiment is summarized in Table 4 . Incubation with the sera starts 4 h after VSV infection of the BW5 cells. The synthesis of VSV proteins at this time is known still to be taking place (Witte & Baltimore, 1977) , but the synthesis of other proteins, including those of MuLV, is inhibited. After incubation with rat anti-Gross and GARa-ferritin (in all taking 2 h) most of the MuLV gps from the cell surface were internalized and in this case the majority of the VSV particles that were produced during the incubation with monoclonal 19-E 12 were not pseudotypes. This could be the explanation for the results of this experiment: many cytoplasmic vacuoles contain ferritin; the cell surface is less labelled with ferritin than in comparable experiments described in Table 3 , but is extensively labelled with haemocyanin. Only a few VSV particles were partially labelled with ferritin (MuLV antigens), whereas half of the VSV were partially labelled with haemocyanin (Thy-1.1) (Fig. 11 a, b) . This implies that many VSV particles with Thy-1 antigens have no detectable MuLV envelope components. Therefore, we may conclude that Thy-1.1 gps can also be incorporated in the VSV envelope. 
First antiserum/conjugate
Rat anti-Gross/ GARa-ferritin Rat anti-Gross/ GARa-ferritin Table 4 .
Distribution of Thy-l.1 and MuLV antigens on the envelope of M u L V and VSV produced by VSV-infected B W5 cells
MuLV envelope* VSV envelope* .g A
#" ~F h
Second antiserum/conjugate Ferritin Haemocyanin Ferritin Haemocyanm Monoclonal 19-E12/ + + + +, -+, -+, -GAM-haemocyanin Buffer/GAM-haemocyanin + + + -+, --* Labelling of virus envelope: + + +, labelled all over; +, -, about half of the virus partially labelled and half negative; +, -, some virus partially labelled; -, not labelled.
DISCUSSION
In this paper we confirm the results from our previous study that no H-2 antigens could be demonstrated in the M u L V envelope when monoctonal antibodies against H-2 were used (Calafat et al., 1981) . W h e n conventional anti-H-2 sera were tested some positive reaction was found with the M u L V envelope due to contamination of these sera with antibodies against MuLV. The same results were obtained with the VSV envelope, i.e. no reaction with monoclonal antibodies against H-2 and some reaction with conventional anti-H-2 sera. This reaction was weaker than with MuLV. It seems quite certain that this positivity is a reaction of V S V ( M u L V ) pseudotypes with antibodies against M u L V present in the conventional sera. This could also be the explanation for the H-2 activity found in VSV by H e c h t & S u m m e r s (1972, 1976 ) who used the inhibition of i m m u n e cytolysis with conventional anti-H-2 sera, without appropriate controls.
H e c h t & Summers (1972, 1976) reported a loss of H-2 antigens from the cell surface of several mouse cell lines after VSV infection. They gave as a possible explanation of these results that this decrease in H-2 positivity of the cell m e m b r a n e is a result of inclusion of the H-2 antigen in the viral envelope of VSV. We have also found a decrease of H-2 in the BW5 cell surface after VSV infection. However, no H-2 antigens were found on the envelope of VSV produced by these cells.
These studies are relevant to the function of cellular and viral antigens on the surface of cells and virions in antiviral immunity. Cytotoxic T lymphocytes (CTL) are the main factor capable of destroying virus-infected cells in the body, as opposed to antiviral antibodies which are instrumental in removing circulating virions from body fluids. In order to accomplish killing, CTLs must recognize both viral antigens and H-2 antigens on the target cell. This conclusion is based purely on the specificity tests of the CTL: innumerable experiments in the past decade have substantiated the phenomenon of H-2 restriction (Zinkernagel & Doherty, 1979) but the final evidence for the mechanism underlying the dual specificity (H-2 and virus) of the CTL has not yet been provided. Complexes of viral antigens and H-2 antigens on the cell surface might be responsible for this phenomenon. For several viruses such complexes have been demonstrated beyond any doubt (for references, see Calafat et al., 1981) , the most spectacular case being the Semliki Forest virus (Helenius et al., 1978) . However, as mentioned above, for some viruses, including MuLV which is subject to H-2 restriction, no evidence for complexes of viral and H-2 antigens is provided. To what extent subthreshold numbers (as far as the present methods are concerned) of such complexes could still present sufficient targets for the CTL remains to be shown.
The gps Pgp-1 and T-200 were present in large amounts on the surface of BW5 and BuEL4 cells as could be demonstrated by the extensive labelling with corresponding monoclonal antibodies. However, none of these gps is incorporated in the envelopes of VSV and MuLV during budding from these cell membranes. Striking was the presence of Thy-1 gp in the envelope of both viruses. Our data show that the positive reaction is not due to contamination of these monoclonal antibodies with antibodies against MuLV, because monoclonal antibodies T24/31 and 19-VE12 are culture supernatants of the hybridomas and neither of these two antibodies nor 19-E12 reacted with the L1210 cell line (MuLV +, Thy-1.2-). The fact that these antibodies do not react with LI210 suggests also that their positive reaction with MuLV and VSV is not due to a reaction with a similar epitope present in Thy-1 protein and one or more of the proteins of MuLV. Moreover, to exclude the possibility that monoclonal antibodies T24/31 and 19-E12 recognize carbohydrate determinants which may also occur at low frequency on some of the viral glycoproteins produced by these Thy-1 + cell lines, the following experiment was done (data not shown): BW5 cells were grown in the presence of the antibiotic tunicamycin (an inhibitor of N-linked glycosylation) at 2 ~tg/ml for 24 h (Ploegh et al., 1981) . In a parallel experiment, [3H]fucose was added 6 h after pretreatment with the antibiotic and the cells were allowed to incorporate for 18 h. There was 76-4 ~ inhibition of incorporation of [3H]fucose in the cells grown in the presence of tunicamycin in comparison with those grown without antibiotic. After incubation of tunicamycin-treated BW5 cells with each monoclonal antibody separately the same reaction on the cell membrane and on the MuLV particles was found as with untreated BW5 cells. It may be concluded that the carbohydrate side chains of Thy-1 gp (for the structure of Thy-1 glycoprotein, see Williams & Gagnon, 1982) are not the epitopes recognized by these monoclonal antibodies. It is also interesting that we could identify the presence of Thy-1 antigens on MuLV and VSV with two monoclonal antibodies directed against two different Thy-1 epitopes, i.e. T24/31 against Thy-1, therefore reacting with virus produced by both the BW5 (Thy-1.1 +) and BuEL4 (Thy-1.2 +) cell lines, and 19-E12 and 19-VE12 against Thy-1.1 and reacting with virus produced by the BW5 (Thy-l. 1 +) cell line.
As already mentioned in Introduction, enveloped viruses in general exclude host gps from the cell surface during assembly of the envelope. In this study we have shown that although cell surface gps H-2, Pgp-1 and T-200 were indeed excluded from the envelopes of MuLV and VSV, Thy-1 gp was incorporated in the envelope of these viruses. The membrane proteins coded by the enveloped RNA virus genome are of two major classes: gps that form spikes on the external surface of the lipid bilayer, and non-glycosylated proteins (generally called M proteins) associated with the inner aspect of the virus envelope. Many studies (for review, see Simons & Garoff, 1980) indicate that the M proteins play a crucial role in the budding process of myxo-, paramyxo-, rhabdo-and retroviruses. It is reasonable to assume that incorporation of M proteins underneath the cell membrane serves as a budding site both for the nucleocapsid inside and for the assembly of the viral glycoproteins on the cell surface. Two explanations might account for the presence of Thy-1 on the virus envelope. One possibility is that Thy-1 has a lateral affinity with viral gps that is stronger than the forces tending to exclude Thy-1 from budding virions. The results of this paper show that this explanation is unlikely in the case of MuLV. In tests for co-patching on the surface of BW5 leukaemia cells, labelled MuLV antigens and labelled Thy-1.1 antigens are localized separately on the same cell. These experiments showed the independent movement of MuLV and Thy-1.1 antigens on the cell membrane and lack of any strong physical association between the two antigens. Another explanation is that Thy-1 gp may just accidentally possess a structure to some extent resembling viral gp and enabling an interaction with the M proteins. As already suggested by Lodish & Porter (1980) it will be of great interest to examine cellular proteins which are incorporated into enveloped RNA viruses for a possible structural homology with viral proteins. This may provide insight into the specificity involved in the maturation of these viruses, the ability to exclude certain host surface polypeptides and to incorporate other cellular and viral surface proteins.
McGrath et al. (1980) prepared rat monoclonal antibodies to the AKR'mouse T lymphoma KKT-2 that were screened independently for blockage of MuLV binding and for cytostatic activity on KKT-2 cells. Four monoclonal antibodies were cytostatic, blocked virus binding and inhibited growth of KKT-2 cells. Three of these antibodies detected determinants on the Thy-1 molecule. The same phenomena on the KKT-2 cells were found by these authors with monoclonal antibody 19-XE5 prepared by Dr M. E. Lostrom, which precipitates a 27 000 dalton protein similar to the protein precipitated by antibody 19-E12 used in this paper and also provided by Dr Lostrom (Bernstein et al., 1980) . Therefore, we can conclude that with monoclonal antibody 19-E12 we detected a Thy-1.1 molecule on the BW5 cell line (also an AKR mouse T lymphoma) that can be a viral receptor for a leukaemogenic MuLV. At present, we do not know whether this can explain the presence of Thy-1 in the MuLV envelope.
